UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 2.723

Sortiert nach

Chelating agents for neurodegenerative diseases

Current medicinal chemistry, 2012, Vol.19 (17), p.2760

2012

Link zum Volltext

Verfügbarkeit prüfen

Whole genome expression profiling of the medial and lateral substantia nigra in Parkinson's disease

Neurogenetics, 2006-03, Vol.7 (1), p.1-11

2006

Link zum Volltext

Verfügbarkeit prüfen

Transcriptome analysis reveals link between proteasomal and mitochondrial pathways in Parkinson's disease

Neurogenetics, 2006-07, Vol.7 (3), p.139-148

2006

Link zum Volltext

Verfügbarkeit prüfen

ALTERATIONS IN THE LEVELS OF IRON, FERRITIN AND OTHER TRACE METALS IN PARKINSON'S DISEASE AND OTHER NEURODEGENERATIVE DISEASES AFFECTING THE BASAL GANGLIA

Brain (London, England : 1878), 1991-08, Vol.114 (4), p.1953-1975

1991

Link zum Volltext

Verfügbarkeit prüfen

Comparative study of commercially available anti-α-synuclein antibodies

Neuropathology and applied neurobiology, 2006-06, Vol.32 (3), p.351-356

2006

Link zum Volltext

Verfügbarkeit prüfen

Dose- and sex-dependent effects of the neurotoxin 6-hydroxydopamine on the nigrostriatal dopaminergic pathway of adult rats: differential actions of estrogen in males and females

Neuroscience, 2003-01, Vol.116 (1), p.213-222

2003

Link zum Volltext

Verfügbarkeit prüfen

Glutathione-related enzymes in brain in Parkinson's disease

Annals of neurology, 1994-09, Vol.36 (3), p.356-361

1994

Link zum Volltext

Verfügbarkeit prüfen

Neuroprotective effects of metabotropic glutamate receptor ligands in a 6-hydroxydopamine rodent model of Parkinson's disease

The European journal of neuroscience, 2005-10, Vol.22 (7), p.1799-1806

2005

Link zum Volltext

Verfügbarkeit prüfen

Increased Nigral Iron Content and Alterations in Other Metal Ions Occurring in Brain in Parkinson's Disease

Journal of neurochemistry, 1989-06, Vol.52 (6), p.1830-1836

1989

Link zum Volltext

Verfügbarkeit prüfen

Oxidative stress as a cause of nigral cell death in Parkinson's disease and incidental lewy body disease

Annals of neurology, 1992, Vol.32 (S1), p.S82-S87

1992

Link zum Volltext

Verfügbarkeit prüfen

Basal Lipid Peroxidation in Substantia Nigra Is Increased in Parkinson's Disease

Journal of neurochemistry, 1989-02, Vol.52 (2), p.381-389

1989

Link zum Volltext

Verfügbarkeit prüfen

Mitochondrial function, GSH and iron in neurodegeneration and Lewy body diseases

Journal of the neurological sciences, 1998-06, Vol.158 (1), p.24-29

1998

Link zum Volltext

Verfügbarkeit prüfen

Cortical Lewy bodies and Aβ burden are associated with prevalence and timing of dementia in Lewy body diseases

Neuropathology and applied neurobiology, 2016-08, Vol.42 (5), p.436-450

2016

Link zum Volltext

Verfügbarkeit prüfen

Inhibition of Leptin-ObR Interaction Does not Prevent Leptin Translocation Across a Human Blood-Brain Barrier Model

Journal of neuroendocrinology, 2016-06, Vol.28 (6), p.np-n/a

2016

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of the effects of swainsonine, captopril, tangeretin and nobiletin on the biological behaviour of brain tumour cells in vitro

Neuropathology and applied neurobiology, 2001-02, Vol.27 (1), p.29-39

2001

Link zum Volltext

Verfügbarkeit prüfen

Full and partial peroxisome proliferation-activated receptor-gamma agonists, but not delta agonist, rescue of dopaminergic neurons in the 6-OHDA Parkinsonian model is associated with inhibition of microglial activation and MMP expression

Journal of neuroimmunology, 2012-05, Vol.246 (1), p.69-77

2012

Link zum Volltext

Verfügbarkeit prüfen

Nicotinamide N-methyltransferase expression in SH-SY5Y neuroblastoma and N27 mesencephalic neurones induces changes in cell morphology via ephrin-B2 and Akt signalling

Cell death & disease, 2013-06, Vol.4 (6), p.e669-e669

2013

Link zum Volltext

Verfügbarkeit prüfen

Indices of oxidative stress and mitochondrial function in individuals with incidental Lewy body disease

Annals of neurology, 1994-01, Vol.35 (1), p.38-44

1994

Link zum Volltext

Verfügbarkeit prüfen

The antioxidant drink "effective microorganism-X (EM-X)" pre-treatment attenuates the loss of nigrostriatal dopaminergic neurons in 6-hydroxydopamine-lesion rat model of Parkinson's disease

Journal of pharmacy and pharmacology, 2004-05, Vol.56 (5), p.649-654

2004

Link zum Volltext

Verfügbarkeit prüfen

Effects of anaesthetics on the loss of nigrostriatal dopaminergic neurons by 6-hydroxydopamine in rats

Journal of Neural Transmission, 2006-05, Vol.113 (5), p.583-591

2006

Link zum Volltext

Verfügbarkeit prüfen

Decreased Ferritin Levels in Brain in Parkinson's Disease

Journal of neurochemistry, 1990-07, Vol.55 (1), p.16-20

1990

Link zum Volltext

Verfügbarkeit prüfen

Increased levels of lipid hydroperoxides in the parkinsonian substantia nigra: An HPLC and ESR study

Movement disorders, 1994, Vol.9 (1), p.92-97

1994

Link zum Volltext

Verfügbarkeit prüfen

Tissue distribution and neuroprotective effects of citrus flavonoid tangeretin in a rat model of Parkinson's disease

Neuroreport, 2001-12, Vol.12 (17), p.3871-3875

2001

Link zum Volltext

Verfügbarkeit prüfen

Analysis of alpha-synuclein, dopamine and parkin pathways in neuropathologically confirmed parkinsonian nigra

Acta neuropathologica, 2007-03, Vol.113 (3), p.253-263

2007

Link zum Volltext

Verfügbarkeit prüfen

Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia

Annals of neurology, 1994-09, Vol.36 (3), p.348-355

1994

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 2.723

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(2.219)
Mit Volltextzugriff
(2.312)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(1.683)
Life Sciences & Biomedicine
(1.310)
Humans
(786)
Biological And Medical Sciences
(525)
Animals
(435)
Male
(425)
Female
(359)
Medical Sciences
(341)
Physical Sciences
(301)
Middle Aged
(213)
Adult
(198)
Fundamental And Applied Biological Sciences. Psychology
(195)
Aged
(180)
Mice
(179)
Biochemistry & Molecular Biology
(174)
Technology
(151)
Social Sciences
(146)
Chemistry
(131)
Old Medline
(128)
Neurosciences & Neurology
(122)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Anesthesia And Analgesia
(52)
Anesthesiology
(36)
Cancer Research
(36)
Journal Of Bacteriology
(35)
Astronomy And Astrophysics
(34)
Physical Review
(33)
Blood
(31)
Journal Of The American Chemical Society
(26)
Soil & Tillage Research
(25)
Archives Of Biochemistry And Biophysics
(23)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Chelating agents for neurodegenerative diseases

Whole genome expression profiling of the medial and lateral substantia nigra in Parkinson's disease

Transcriptome analysis reveals link between proteasomal and mitochondrial pathways in Parkinson's disease

ALTERATIONS IN THE LEVELS OF IRON, FERRITIN AND OTHER TRACE METALS IN PARKINSON'S DISEASE AND OTHER NEURODEGENERATIVE DISEASES AFFECTING THE BASAL GANGLIA

Comparative study of commercially available anti-α-synuclein antibodies

Dose- and sex-dependent effects of the neurotoxin 6-hydroxydopamine on the nigrostriatal dopaminergic pathway of adult rats: differential actions of estrogen in males and females

Glutathione-related enzymes in brain in Parkinson's disease

Neuroprotective effects of metabotropic glutamate receptor ligands in a 6-hydroxydopamine rodent model of Parkinson's disease

Increased Nigral Iron Content and Alterations in Other Metal Ions Occurring in Brain in Parkinson's Disease

Oxidative stress as a cause of nigral cell death in Parkinson's disease and incidental lewy body disease

Basal Lipid Peroxidation in Substantia Nigra Is Increased in Parkinson's Disease

Mitochondrial function, GSH and iron in neurodegeneration and Lewy body diseases

Cortical Lewy bodies and Aβ burden are associated with prevalence and timing of dementia in Lewy body diseases

Inhibition of Leptin-ObR Interaction Does not Prevent Leptin Translocation Across a Human Blood-Brain Barrier Model

Evaluation of the effects of swainsonine, captopril, tangeretin and nobiletin on the biological behaviour of brain tumour cells in vitro

Full and partial peroxisome proliferation-activated receptor-gamma agonists, but not delta agonist, rescue of dopaminergic neurons in the 6-OHDA Parkinsonian model is associated with inhibition of microglial activation and MMP expression

Nicotinamide N-methyltransferase expression in SH-SY5Y neuroblastoma and N27 mesencephalic neurones induces changes in cell morphology via ephrin-B2 and Akt signalling

Indices of oxidative stress and mitochondrial function in individuals with incidental Lewy body disease

The antioxidant drink "effective microorganism-X (EM-X)" pre-treatment attenuates the loss of nigrostriatal dopaminergic neurons in 6-hydroxydopamine-lesion rat model of Parkinson's disease

Effects of anaesthetics on the loss of nigrostriatal dopaminergic neurons by 6-hydroxydopamine in rats

Decreased Ferritin Levels in Brain in Parkinson's Disease

Increased levels of lipid hydroperoxides in the parkinsonian substantia nigra: An HPLC and ESR study

Tissue distribution and neuroprotective effects of citrus flavonoid tangeretin in a rat model of Parkinson's disease

Analysis of alpha-synuclein, dopamine and parkin pathways in neuropathologically confirmed parkinsonian nigra

Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia

Suchergebnisse filtern